Phaeosynt Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $150K

  • Investors
  • 15

Phaeosynt General Information

Description

Manufacturer of animal-free antibodies intended for the research and diagnostic industries. The company's technology utilizes microalgae to produce reproducible batches of antibodies and fusion proteins, enabling diagnostic manufacturers and consumer brands to access serum-free biological components and white-label rapid test solutions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Walderseestr. 7Feodor-Lynen-Street 31
  • 30625 Hanover
  • Germany
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • Walderseestr. 7Feodor-Lynen-Street 31
  • 30625 Hanover
  • Germany

Phaeosynt Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phaeosynt Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 14-Sep-2026 $150K Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
6. Seed Round 12-Feb-2025 Completed Generating Revenue
5. Accelerator/Incubator 16-Dec-2024 Completed Generating Revenue
4. Seed Round 01-Dec-2023 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
1. Accelerator/Incubator 18-Jul-2022 Completed Startup
To view Phaeosynt’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Phaeosynt Patents

Phaeosynt Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250314652-A1 Immunoassay for detecting biologically active proteins Pending 15-Sep-2022
EP-4587833-A1 Immunoassay for verifying biologically active proteins Active 15-Sep-2022
EP-4587833-B1 Immunoassay for verifying biologically active proteins Active 15-Sep-2022
EP-4587833-C0 Immunoassay for verifying biologically active proteins Active 15-Sep-2022
WO-2024056905-A1 Immunoassay for verifying biologically active proteins Inactive 15-Sep-2022 G01N33/54388
To view Phaeosynt’s complete patent history, request access »

Phaeosynt Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phaeosynt Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Morgan Stanley Inclusive & Sustainable Ventures Accelerator/Incubator Minority
Nordic Mentor Network For Entrepreneurship Accelerator/Incubator
Fonde Ventures Accelerator/Incubator Minority
NBank Capital Venture Capital Minority
PSD Braunschweig Verwaltungs Corporate Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Phaeosynt FAQs

  • When was Phaeosynt founded?

    Phaeosynt was founded in 2021.

  • Where is Phaeosynt headquartered?

    Phaeosynt is headquartered in Hanover, Germany.

  • What is the size of Phaeosynt?

    Phaeosynt has 10 total employees.

  • What industry is Phaeosynt in?

    Phaeosynt’s primary industry is Biotechnology.

  • Is Phaeosynt a private or public company?

    Phaeosynt is a Private company.

  • What is Phaeosynt’s current revenue?

    The current revenue for Phaeosynt is .

  • How much funding has Phaeosynt raised over time?

    Phaeosynt has raised $1.91M.

  • Who are Phaeosynt’s investors?

    Morgan Stanley Inclusive & Sustainable Ventures, Nordic Mentor Network For Entrepreneurship, Fonde Ventures, NBank Capital, and PSD Braunschweig Verwaltungs are 5 of 15 investors who have invested in Phaeosynt.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process